Japan to fund polio vaccination efforts in Pakistan

NewsGuard 100/100 Score

The Japan International Cooperation Agency (JICA) is providing approximately $65 million to Pakistan's government to provide polio vaccination campaigns in the country, "one of the most difficult fronts against the disease as global health organizations risk missing their goal of stopping polio globally the end of 2012," the Wall Street Journal reports. "If Pakistan achieves certain goals with the money, the Bill & Melinda Gates Foundation will repay the loan to Japan, according to officials briefed on the plan," according to the newspaper (Guth, 8/18).

"The loan is underpinned by an innovative financing approach referred to as a 'Loan Conversion' mechanism," a Gates Foundation press release states (8/17). The Wall Street Journal reports that the loan "is structured as a line of credit that Pakistan can draw down through 2015, according to [a] Gates Foundation official. The foundation will repay the loan on behalf of Pakistan if the country immunizes certain numbers of children, the official said." The newspaper notes that the Gates Foundation and JICA "expect to fund similar loans in other countries, according to a official at the Gates Foundation in Seattle" (8/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global study reveals mismatch in COVID-19 treatment guidelines with WHO standards